Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$142.14

1.54 (1.10%)

09:21
11/06/18
11/06
09:21
11/06/18
09:21

Johnson & Johnson announces data from two studies of photochromic contact lenses

Johnson & Johnson Vision announced that data from two new studies on the visual effects of photochromic contact lenses will be presented at the 2018 American Academy of Optometry Annual Meeting in San Antonio. Both studies are among the 'most newsworthy' at the meeting, as selected by the American Academy of Optometry. These are the first scientific presentations focused on photochromic contact lens technology since the lenses received clearance from FDA in April.

  • 12

    Nov

JNJ Johnson & Johnson
$142.14

1.54 (1.10%)

10/23/18
PIPR
10/23/18
NO CHANGE
PIPR
Overweight
Piper says Theravance data shows 'disruptive potential' of oral JAK inhibitor
After Theravance Biopharma (TBPH) presented four-week data from the Phase Ib ulcerative colitis study of TD-1473, a gut-selective pan-JAK inhibitor for the treatment of inflammatory bowel disease, at the United European Gastroenterology Week, Piper Jaffray analyst Tyler Van Buren said the data provides substantial proof of concept and shows the "disruptive potential" that could lead to "multi-billion" global sales for Theravance and partner Janssen (JNJ). He maintains an Overweight rating on Theravance shares.
10/24/18
JEFF
10/24/18
NO CHANGE
Target $50
JEFF
Buy
Pacira's strong Exparel trends continue, says Jefferies
Jefferies analyst David Steinberg says the 30.3% year-over-year gain for Symphony Health sales data in September suggests Pacira Pharmaceuticals' (PCRX) Exparel is continuing to accelerate. Exparel has now posted double digit year-over-year gains in 11 of the last 12 months arguably due to a strong nerve block launch and a Johnson & Johnson (JNJ) partnership that "may be hitting stride," Steinberg tells investors in a research note. The analyst sees the possibility for "significant upside" next year due to Centers for Medicare & Medicaid Services' unbundling in the ambulatory care setting. He keeps a Buy rating on Pacira with a $50 price target.
10/25/18
WELS
10/25/18
NO CHANGE
WELS
Wells Fargo says Trump speech today won't be end of drug pricing proposals
Wells Fargo analyst David Maris notes that Politico and other media outlets are reporting that President Donald Trump will propose several new initiatives to address high drug prices when he speaks later today at the U.S. Department of Health and Human Services. Maris thinks Trump's focus will be on how other countries are "freeloading" on U.S. innovation with lower negotiated pricing, stating that news reports make it appear that the administration is targeting the industry for action, rather than other countries to raise their spending. While Maris acknowledges the timing of the speech being near the mid-term elections, he believes these proposals are simply the follow-though of earlier promises. He also expects this is not the end of proposals to address the issue of U.S. drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
10/29/18
MSCO
10/29/18
NO CHANGE
Target $153
MSCO
Equal Weight
Morgan Stanley says ruling on J&J's Zytiga patent not a surprise
Morgan Stanley analyst David Lewis said it was not a surprise that Johnson & Johnson lost a ruling over the patent of its prostate cancer drug Zytiga and he has already been expecting generics to enter the U.S. market after a 30-month stay expires this month. He forecasts a 50% decline in Zytiga in Q4 and while J&J did not specifically model a generic entry, Lewis believes its guidance range imbedded pressure from potential generic Zytiga competition. The analyst, who said trends and commentary last quarter made him more comfortable with his above-market forecast for 5%-6% Pharma growth in 2019 for Johnson & Johnson, keeps an Equal Weight rating on J&J shares.

TODAY'S FREE FLY STORIES

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

, INTC

Intel

$51.32

-0.07 (-0.14%)

15:11
02/20/19
02/20
15:11
02/20/19
15:11
Periodicals
Intel calls embedded MRAM ready for high-volume manufacturing, EE Times says »

Intel (INTC), in a paper…

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

INTC

Intel

$51.32

-0.07 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 14

    Mar

  • 14

    Mar

  • 25

    Mar

  • 26

    Mar

NOG

Northern Oil and Gas

$2.56

0.04 (1.59%)

15:10
02/20/19
02/20
15:10
02/20/19
15:10
Options
Notable call buying in Northern Oil and Gas »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices down…

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices up…

NTES

NetEase

$231.03

1.48 (0.64%)

15:04
02/20/19
02/20
15:04
02/20/19
15:04
Options
NetEase options imply 10.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ITHUF

iAnthus

$0.00

(0.00%)

15:02
02/20/19
02/20
15:02
02/20/19
15:02
Periodicals
Breaking Periodicals news story on iAnthus »

Hedgeye names iAnthus a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXP

Eagle Materials

$77.88

1.21 (1.58%)

15:00
02/20/19
02/20
15:00
02/20/19
15:00
Options
Notable call buying in Eagle Materials as shares fly to multi-month highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MCS

Marcus

$40.94

1.35 (3.41%)

, NCMI

National CineMedia

$7.13

0.11 (1.57%)

14:57
02/20/19
02/20
14:57
02/20/19
14:57
Hot Stocks
Marcus announces affiliate partnership for Movie Tavern with National CineMedia »

National CineMedia (NCMI)…

MCS

Marcus

$40.94

1.35 (3.41%)

NCMI

National CineMedia

$7.13

0.11 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

14:50
02/20/19
02/20
14:50
02/20/19
14:50
General news
Treasury Action: there wasn't any strong reaction to the FOMC minutes »

Treasury Action: there…

SSNLF

Samsung

$0.00

(0.00%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Hot Stocks
Samsung introduces new line of Galaxy S10 phones »

Samsung inroduced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$7.28

0.33 (4.75%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Options
Vipshop options imply 15.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SSNLF

Samsung

$0.00

(0.00%)

, TMUS

T-Mobile

$72.78

0.27 (0.37%)

14:47
02/20/19
02/20
14:47
02/20/19
14:47
Hot Stocks
Samsung unveils Galaxy Fold »

Samsung Electronics…

SSNLF

Samsung

$0.00

(0.00%)

TMUS

T-Mobile

$72.78

0.27 (0.37%)

T

AT&T

$30.87

0.24 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

  • 20

    Mar

VRTU

Virtusa

$50.50

-0.61 (-1.19%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Conference/Events
Virtusa management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 19

    Mar

ADI

Analog Devices

$106.55

2.34 (2.25%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 13

    Mar

  • 09

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Samsung unveils Galaxy Watch Active, Galaxy Fit, and Galaxy Buds »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAK

Northern Dynasty

$0.89

0.0029 (0.33%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Northern Dynasty says Pebble Project Draft Environmental Impact Statement posted »

Northern Dynasty Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$97.56

0.53 (0.55%)

14:42
02/20/19
02/20
14:42
02/20/19
14:42
Conference/Events
Tractor Supply management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 06

    Mar

PWR

Quanta Services

$36.49

0.815 (2.28%)

14:40
02/20/19
02/20
14:40
02/20/19
14:40
Options
Repeat put buyers in Quanta Services ahead of earnings »

Repeat put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EADSY

Airbus

$0.00

(0.00%)

14:38
02/20/19
02/20
14:38
02/20/19
14:38
Conference/Events
Airbus management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NTR

Nutrien

$54.57

1.22 (2.29%)

14:35
02/20/19
02/20
14:35
02/20/19
14:35
Options
Nutrien put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 27

    Feb

14:35
02/20/19
02/20
14:35
02/20/19
14:35
General news
On the balance sheet: »

On the balance sheet: the…

SSNLF

Samsung

$0.00

(0.00%)

, VZ

Verizon

$55.67

0.24 (0.43%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Periodicals
Samsung unveils Galaxy S10 5G, Verge reports »

Samsung (SSNLF) intends…

SSNLF

Samsung

$0.00

(0.00%)

VZ

Verizon

$55.67

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

FDP

Fresh Del Monte

$29.80

0.53 (1.81%)

14:34
02/20/19
02/20
14:34
02/20/19
14:34
Hot Stocks
Breaking Hot Stocks news story on Fresh Del Monte »

Fresh Del Monte trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

, AMGN

Amgen

$187.14

0.17 (0.09%)

14:27
02/20/19
02/20
14:27
02/20/19
14:27
Recommendations
Cytokinetics, Amgen analyst commentary  »

Piper reiterates…

CYTK

Cytokinetics

$7.52

-0.17 (-2.21%)

AMGN

Amgen

$187.14

0.17 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 28

    Feb

  • 01

    Mar

GG

Goldcorp

$11.52

0.25 (2.22%)

14:25
02/20/19
02/20
14:25
02/20/19
14:25
Options
Goldcorp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.